|
|
Volumn 9, Issue 8, 2002, Pages 913-921
|
|
Use of serial FDG pet to measure the response of bone-dominant breast cancer to therapy
a
a
a
a
a
a
a
|
|
Author keywords
Breast neoplasms, diagnostic radiology; Breast neoplasms, emission CT; Breast neoplasms, metastases; Imaging
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CA 27.29 ANTIGEN;
CAPECITABINE;
CARCINOEMBRYONIC ANTIGEN;
DOCETAXEL;
FLUORODEOXYGLUCOSE F 18;
MEGESTROL ACETATE;
NAVELBINE;
PAMIDRONIC ACID;
TAMOXIFEN;
TRASTUZUMAB;
TUMOR MARKER;
UNCLASSIFIED DRUG;
CA 27-29 ANTIGEN;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
TUMOR ANTIGEN;
ARTICLE;
BONE METASTASIS;
BREAST CARCINOMA;
CANCER DIAGNOSIS;
CANCER STAGING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DIAGNOSTIC IMAGING;
FEMALE;
HUMAN;
MULTIMODALITY CANCER THERAPY;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
WHOLE BODY SCINTISCANNING;
ADULT;
AGED;
BONE TUMOR;
BREAST TUMOR;
CARCINOMA;
COMPARATIVE STUDY;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
FEASIBILITY STUDY;
METABOLISM;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
RETROSPECTIVE STUDY;
SCINTISCANNING;
ADULT;
AGED;
ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE;
BONE NEOPLASMS;
BREAST NEOPLASMS;
CARCINOMA;
FEASIBILITY STUDIES;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MIDDLE AGED;
RADIOPHARMACEUTICALS;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, EMISSION-COMPUTED;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0035991797
PISSN: 10766332
EISSN: None
Source Type: Journal
DOI: 10.1016/S1076-6332(03)80461-0 Document Type: Article |
|
Times cited : (135)
|
|
References (18)
|
